Target intelligence / Profile preview

Endonuclease 4 (Endo IV) (Endo IV)

Target
Endo IV
Molecular classification
Enzyme, Hydrolase, AP endonuclease, DNA repair protein
01

Overview

Endonuclease IV (Endo IV), encoded by the nfo gene in Escherichia coli, is a vital DNA repair enzyme belonging to the Class II AP endonuclease family (UniProt P0A6B7). It plays a critical role in the base excision repair (BER) pathway by recognizing and cleaving the phosphodiester backbone at apurinic/apyrimidinic (AP) sites, which are common DNA lesions resulting from spontaneous hydrolysis or oxidative damage (PubMed: 2631424). Unlike the more abundant Exonuclease III, Endonuclease IV is specifically induced by oxidative stress and is capable of removing a variety of 3'-blocking groups, such as 3'-phosphoglycolate and 3'-phosphate, to facilitate DNA polymerase activity (PubMed: 2983314). Structurally, it is a TIM-barrel protein that utilizes a tri-zinc center to catalyze the hydrolysis of the DNA backbone (PDB: 1QTW). While not a primary human therapeutic target, it is investigated as an antimicrobial target to sensitize bacteria to DNA-damaging agents and oxidative stress (PubMed: 16439568). Inhibition of this enzyme can lead to the accumulation of lethal DNA breaks in bacterial cells, particularly when combined with other stressors. It serves as a model for understanding the repair of oxidative DNA damage across various species.

Other names
nfoEndonuclease IVApurinic-apyrimidinic endonuclease IVAP endonuclease 2
02

Mechanism of action

Endonuclease IV catalyzes the hydrolysis of the phosphodiester bond 5' to an abasic site, generating a 3'-hydroxyl group and a 5'-deoxyribose-5-phosphate (dRP) terminus (PubMed: 2631424).

03

Biological functions

DNA repairBase excision repairResponse to oxidative stressHydrolysis of phosphodiester bonds
04

Disease associations

Infection
05

Safety considerations

Potential off-target inhibition of human AP endonucleases (e.g., APEX2) due to structural homologyFunctional redundancy with Exonuclease III (xthA) in E. coli may limit the efficacy of single-target inhibition
06

Biomarkers

nfo gene expression levelsBacterial sensitivity to oxidative agentsBacterial DNA damage markers

Beyond the preview

Go deeper on Endonuclease 4 (Endo IV) (Endo IV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endonuclease 4 (Endo IV) (Endo IV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call